- $12.40bn
- $11.80bn
- $2.82bn
- 98
- 27
- 27
- 50
Annual income statement for Teradyne, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,121 | 3,703 | 3,155 | 2,676 | 2,820 |
| Cost of Revenue | |||||
| Gross Profit | 1,786 | 2,207 | 1,867 | 1,537 | 1,649 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,193 | 2,531 | 2,323 | 2,175 | 2,226 |
| Operating Profit | 928 | 1,172 | 832 | 501 | 594 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 901 | 1,161 | 840 | 526 | 609 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 784 | 1,015 | 716 | 449 | 550 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 784 | 1,015 | 716 | 449 | 542 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 784 | 1,015 | 716 | 449 | 542 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.22 | 5.71 | 4.3 | 2.84 | 3.09 |
| Dividends per Share |